Skip to content

Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use

Performance of DAILIES TOTAL1 Daily Disposable Contact Lenses in Habitual Soft Lens Wearers Who Report Substantial Digital Device Use

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06308666
Acronym
FOX
Enrollment
41
Registered
2024-03-13
Start date
2024-03-18
Completion date
2024-10-23
Last updated
2025-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The purpose of this study is to evaluate the performance of DAILIES TOTAL1 daily disposable contact lenses with regards to subjective symptoms (comfort, dryness, vision) in lens wearers who use identify themselves as substantial digital device users (at least eight hours of digital device use per day).

Interventions

Daily disposable silicone hydrogel contact lenses indicated for the optical correction of myopia and hyperopia

Sponsors

Alcon Research
CollaboratorINDUSTRY
University of Waterloo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Are between 18 and 40 years of age (inclusive) and has full legal capacity to volunteer; 2. Have read and signed an information consent letter; 3. Are willing and able to follow instructions and maintain the appointment schedule; 4. Are a digital device user (at least 8 hours on a typical day using any combination of digital devices such as personal computer \[PC\], laptop, smartphone or tablet); 5. Are a habitual wearer of daily wear, spherical, soft contact lenses (no bifocal or multifocal contact lenses, no extended wear or monovision) for at least 5 days/week and at least 13+ hours/day on a typical day during the month prior to enrolment; 6. The habitual lens type brand will be restricted such that a maximum of 7 participants will be included in the study for each lens brand/material; 7. Have a vertex corrected spherical equivalent distance refraction within -0.50 Diopter (D) to -9.00D in each eye; 8. Have a vertex corrected refractive cylinder ≤ -0.75 cylindrical correction in each eye after vertexing to the corneal plane; 9. Demonstrate an acceptable fit and achieves best corrected visual acuity of at least 0.10 logMAR in each eye with DAILIES TOTAL1® contact lenses; 10. Are willing to wear DAILIES TOTAL1® contact lenses at least 5 days per week and 13+ hours per day throughout the study.

Exclusion criteria

1. Are participating in any concurrent clinical or research study involving intervention or invasive ocular tests; 2. Are presbyopic or habitually use a reading addition for close work; 3. Have any known active\* ocular disease and/or infection; \[\* For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and mild dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.\] 4. Meet the diagnosis of dry eye disease as per the following combination: 1. Meets the symptom criteria of Contact Lens Dry Eye Questionnaire (CLDEQ-8) score ≥12 2. And they show 1 of the following 2 signs: * Either sodium fluorescein (NaFl) staining (either \[cornea \>5 dots\] or \[conjunctiva \>9 dots\] or \[lid margin \>2mm length AND ≥25% width\]); * Or non-invasive tear film break-up time (NITBUT) (no contact lens) \<10 seconds. 5. Have a systemic condition that in the opinion of the investigator may affect a study outcome variable;+ \[+ Any potential exclusion will be reviewed with the Lead Investigator or Principal Investigator prior to final decision making.\] 6. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 7. Are a current wearer of DAILIES TOTAL1® daily disposable contact lenses; 8. Have known sensitivity to the diagnostic pharmaceutical sodium fluorescein to be used in the study; 9. Have undergone refractive error surgery; 10. Are a member of the Centre for Ocular Research & Education (CORE) directly involved in the study.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Rating of Comfort After 8 Hours or More of Digital Device UseDay 14+2Participants rate their overall comfort after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).
Subjective Rating of Dryness After 8 Hours or More of Digital Device UseDay 14+2Participants rate their overall dryness after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).
Subjective Rating of Clarity of Vision After 8 Hours or More of Digital Device UseDay 14+2Participants rate their overall clarity of vision after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).

Countries

Canada

Participant flow

Recruitment details

Participants were recruited at a single site between March 2024 and October 2024. The first participant was enrolled on March 18, 2024 and the last participant was enrolled on October 9, 2024.

Pre-assignment details

Out of the 41 participants that were enrolled, 35 met the inclusion critieria, and 35 were dispensed with the study treatment.

Participants by arm

ArmCount
Refit
Refit and dispense participant with delefilcon A contact lenses and evaluate lens performance Delefilcon A contact lenses: Daily disposable silicone hydrogel contact lenses indicated for the optical correction of myopia and hyperopia
35
Total35

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProtocol Violation2
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicRefit
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
35 Participants
Age, Continuous25.5 years
STANDARD_DEVIATION 6.3
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Canada
35 participants
Sex: Female, Male
Female
29 Participants
Sex: Female, Male
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 35
other
Total, other adverse events
0 / 35
serious
Total, serious adverse events
0 / 35

Outcome results

Primary

Subjective Rating of Clarity of Vision After 8 Hours or More of Digital Device Use

Participants rate their overall clarity of vision after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).

Time frame: Day 14+2

Population: 3 people discontinued before the study could be completed.

ArmMeasureValue (MEDIAN)
RefitSubjective Rating of Clarity of Vision After 8 Hours or More of Digital Device Use95 score on a scale
Primary

Subjective Rating of Comfort After 8 Hours or More of Digital Device Use

Participants rate their overall comfort after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).

Time frame: Day 14+2

Population: 3 people discontinued before the study could be completed.

ArmMeasureValue (MEDIAN)
RefitSubjective Rating of Comfort After 8 Hours or More of Digital Device Use96 score on a scale
Primary

Subjective Rating of Dryness After 8 Hours or More of Digital Device Use

Participants rate their overall dryness after 8 hours or more of digital device use on a scale from 0 (worst) to 100 (best).

Time frame: Day 14+2

Population: 3 people discontinued before the study could be completed.

ArmMeasureValue (MEDIAN)
RefitSubjective Rating of Dryness After 8 Hours or More of Digital Device Use93 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026